Outcome of the Board meeting and Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Directors of Dipna Pharmachem Limited met on 22nd April 2026 (2:00 PM to 2:30 PM) and approved two items. First, on the recommendation of the Audit Committee, the Board approved the appointment of M/s. Jay Pandya & Associates, Practicing Company Secretaries based in Ahmedabad, as the Secretarial Auditor of the Company for the financial year 2025-26, subject to shareholder approval. The firm is described as a peer-reviewed entity experienced in company law, securities laws, IPO/FPO advisory, and corporate governance. Second, the Board approved a Postal Ballot notice to seek shareholder approval through remote e-voting, with the voting window running from 23rd April 2026 (9:00 AM) to 22nd May 2026 (5:00 PM).
This is a routine compliance-driven filing with no direct material impact on the company's financials or operations. Shareholders will be asked to vote on the auditor appointment via postal ballot, and the stock price is unlikely to be meaningfully affected.